Latest Biotech News

Yale University enhanced human multiplex genome editing with higher precision, tripling effective edits while reducing off-target effects. A gene therapy breakthrough by a Dutch consortium...

Memorial Sloan Kettering Cancer Center revealed novel mechanisms linking metabolism, gene mutations, and therapeutic resistance in cancers including intestinal and breast cancer. Adaptive...

Novel research in Parkinson’s disease harnesses imaging breakthroughs to detect prodromal non-motor symptoms and employs AI analysis of earwax VOCs as noninvasive diagnostic tools. Personalized...

Researchers introduce AI-powered hyperspectral sensors to precisely assess herbicide effects on weeds, elevating crop management. Advances in machine vision and deep learning automate fruit...

FDA Commissioner Marty Makary articulates a vision for a modernized agency focused on efficiency, AI integration, and faster drug approvals, defending recent workforce reductions. The agency’s new...

New research from VIB-KU Leuven reveals that natural killer (NK) cells may hinder immune checkpoint blockade efficacy in melanoma by excluding CD8 T cells from tumors. Agenus and Noetik...

The U.S. Food and Drug Administration has launched a pilot program offering priority review vouchers to drug developers whose products address identified national health priorities, promising to...

Eli Lilly & Co. agreed to acquire Verve Therapeutics for up to $1.3 billion, including upfront and milestone payments, marking a strategic investment to broaden its cardiovascular pipeline through...

Scholar Rock Pharmaceuticals reported that its investigational myostatin-blocking antibody, apitegromab, successfully preserved lean muscle mass in patients taking Eli Lilly's obesity drug...

Cutting-edge research employing single-cell RNA sequencing and multi-omics is elucidating complex disease mechanisms and identifying novel biomarkers across multiple conditions. Studies have...

Recent developments underscore a transformative era in oncology, where novel immunotherapies and artificial intelligence converge to enhance cancer patient outcomes. Bispecific antibodies...

Researchers are pioneering new sensor and imaging technologies with applications across medicine and environmental monitoring. A perovskite-based image sensor developed by ETH Zurich and Empa...

Artificial intelligence and computational strategies are reshaping biotechnology with accelerated drug design and editing technologies. Insilico Medicine’s Chemistry42 AI platform identified novel...

Recent studies illuminate critical intersections between environmental factors, microbiomes, and human health. Research connects proximity to microplastic-contaminated oceans with elevated...

Recent months have witnessed vibrant financing activity and strategic movements within the biotech sector. Notably, Caris Life Sciences raised $494 million in a public offering to bolster its...

The U.S. Food and Drug Administration (FDA) announced a pilot program introducing a priority review voucher to accelerate the approval process for drugs addressing national health priorities....

Eli Lilly is set to acquire Verve Therapeutics for up to $1.3 billion, including milestone payments, to enhance its cardiovascular disease treatment portfolio with gene-editing therapies. Verve’s...

Recent studies have unveiled novel insights into cancer immunotherapy resistance and predictive biomarker development. VIB-KU Leuven researchers revealed a paradoxical role of natural killer cells...

Artificial intelligence continues to reshape drug discovery with novel protein design platforms. The European Molecular Biology Laboratory introduced AlphaDesign, an AI-driven framework enabling...

Innovations in liver cancer treatment feature prominently with University of Hong Kong researchers securing global approvals for a dual immunotherapy combining nivolumab and ipilimumab to improve...